跳至主要内容
临床试验/NCT01742689
NCT01742689Unknown3 期

Assessment of Analgesic Efficacy of Intranasal Desmopressin in the Treatment of Acute Pain in Patients With Renal Colic

Tehran University of Medical Sciences2 个研究点 分布在 1 个国家目标入组 88 人开始时间: 2012年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
入组人数
88
试验地点
2
主要终点
Pain intensity

研究概览

简要总结

In this study we will compare pain intensity and side effects at different time points after the intranasal administration of desmopressin or placebo in patients with acute renal colic pain.

详细描述

Obstruction of the urinary tract can increase pelvi-ureteric pressure and thus cause renal colic pain, which can be very severe. Conventional therapy consists of non-steroidal anti-inflammatory drugs (NSAIDs) and opioids. NSAIDs have many side effects and opioids are not always available. In addition, the intravenous form of NSAIDs is not routinely available in Iran, and the drug is mainly used in the form of suppository. Due to these reasons, research on newer replacement therapies with fewer side effects is necessary. Desmopressin intranasal spray has already been shown to be partially effective in renal colic pain in a few studies. Due to its lower side effects, we decided to conduct a clinical trial with desmopressin to evaluate pain relief in renal colic. In this study, eighty-eight patients with acute renal colic pain, referring to Imam Khomeini Hospital in Tehran, will be randomly allocated to receive either intranasal desmopressin or placebo. Both groups will also receive 100 milligram indomethacin suppository. Pain intensity will be assessed and recorded using a verbal numeric rating scale, before nasal spray, and in minutes 5, 10, 15, 30, 45 and 60 after receiving the allocated treatment. Possible side effects will also be asked and recorded. The patient and the investigator responsible for recording pain intensity will not be aware of the administered drug. The results will be compared before and after treatment in each group, using appropriate statistical tests.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
15 Years 至 65 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age: 15 to 65 years
  • Pain intensity of at least 3
  • Clinical diagnosis of renal colic

排除标准

  • History of hypertension
  • History of acute myocardial ischemia
  • History of hyponatremia
  • Presence of acute rhinitis and flu
  • Coagulopathy or anticoagulant therapy
  • History of peptic ulcer disease, asthma, renal failure, severe liver failure
  • Analgesic use over 4 hours ago
  • Taking seizure medications (such as carbamazepine)
  • Taking any of the following drugs: chlorpropamide, warfarin, clofibrate , epinephrine, Fludrocortisone, heparin, lithium, alcohol

研究组 & 干预措施

Desmopressin intranasal spray

Experimental

Patients in this arm will receive 40 microgram desmopressin intranasal spray & 100 milligram indomethacin suppository

干预措施: Desmopressin intranasal spray (Drug)

Desmopressin intranasal spray

Experimental

Patients in this arm will receive 40 microgram desmopressin intranasal spray & 100 milligram indomethacin suppository

干预措施: Indomethacin suppository (Drug)

Placebo intranasal spray

Placebo Comparator

Patients in this group will receive placebo nasal spray & 100 milligram indomethacin suppository

干预措施: Placebo intranasal spray (Drug)

Placebo intranasal spray

Placebo Comparator

Patients in this group will receive placebo nasal spray & 100 milligram indomethacin suppository

干预措施: Indomethacin suppository (Drug)

结局指标

主要结局

Pain intensity

时间窗: baseline till one hour

Changes in pain intensity using a verbal numeric rating scale

次要结局

  • Side effects(One hour)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验